James F. Caravelli

Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma

Craig H. Moskowitz, Heiko Schöder, Julie Teruya‐Feldstein et al. · Journal of Clinical Oncology · 2010 · 326 citations · Full text

Medicine, Oncology, Radiology +14

Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

R T Heelan, Valerie W. Rusch, Colin B. Begg et al. · American Journal of Roentgenology · 1999 · 292 citations

Medicine, Oncology, Surgery +17

Superior sulcus tumors: CT and MR imaging.

R T Heelan, Barbara E. Demas, James F. Caravelli et al. · Radiology · 1989 · 200 citations

Medicine, Oncology, Radiology +15

Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome

Gianfranco U. Meduri, Diane E. Stover, Marjorie Lee et al. · The American Journal of Medicine · 1986 · 191 citations

Medicine, Immunology, Infectious Diseases +12

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.

David J. Straus, Jeffrey J. Gaynor, Jane Myers et al. · Journal of Clinical Oncology · 1990 · 164 citations

Medicine, Oncology, Radiation Oncology +15